🔎 Trials Near Me

Akèy › Kansè (tout kalite) › Distrik Columbia › Washington

Etid klinik pou Kansè (tout kalite) nan Washington, DC

58 etid pou Kansè (tout kalite) ap chèche patisipan nan sit nan ak bò kote Washington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Clinical and Genetic Studies of Li-Fraumeni Syndrome

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • National Cancer Institute - Shady Grove, Bethesda · 7 mi lwen
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Tout laj · Tout sèks · Mizajou Oct 2, 2026 · NCT01443468

Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
4 Weeks · Tout sèks · Mizajou Oct 2, 2026 · NCT01109394

Evaluation for NCI Surgery Branch Clinical Research Protocols

Ap rekriteEtid obsèvasyon
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT00001823

Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis

Ap rekriteEtid obsèvasyon
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 3 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT01441089

Tumor Related Epilepsy

Ap rekriteEtid obsèvasyon
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 8 a 99 · Tout sèks · Mizajou Oct 2, 2026 · NCT02639325

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

Ap rekriteFaz 1
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 a 120 · Tout sèks · Mizajou Oct 2, 2026 · NCT06885697

A Natural History Study of Metabolic Sizing in Health and Disease

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 2 a 99 · Tout sèks · Mizajou Oct 1, 2026 · NCT05398783

A Study of ASP3082 in Adults With Advanced Solid Tumors

Ap rekriteFaz 1
  • Georgetown University Hospital, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT05382559

Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 2 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT00026884

A Study of PHN-012 in Patients With Advanced Solid Tumors

Ap rekriteFaz 1
  • PHN-012-001 Site, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07127874

Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 2 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT00033137

Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma

Ap rekriteFaz 1/2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 a 99 · Tout sèks · Mizajou Sep 28, 2026 · NCT07416188

Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer

Ap rekriteEtid obsèvasyon
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 a 120 · Tout sèks · Mizajou Sep 28, 2026 · NCT00006518

Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel

Ap rekriteFaz 2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 a 120 · Tout sèks · Mizajou Sep 28, 2026 · NCT04449549

A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism

Ap rekriteFaz 3
  • Investigative Site, Bethesda · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06881992

Collection of Blood From Patients With Cancer

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT00034216

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Ap rekriteFaz 2/3
  • Georgetown University Medical Center - Department of Pharmacy, Oncology Pharmacy, Washington D.C.
  • Georgetown University Medical Center, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06989437

Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Ap rekriteFaz 2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 a 85 · Tout sèks · Mizajou Sep 24, 2026 · NCT03986034

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

Ap rekriteFaz 3
  • MedStar Georgetown University Hospital / Lombardi Comprehensive Cancer Center, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06901531

5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors

Ap rekriteFaz 1
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 a 120 · Tout sèks · Mizajou Sep 22, 2026 · NCT03366116

Collection of Tissue Samples for Cancer Research

Ap rekriteEtid obsèvasyon
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
2 Months · Tout sèks · Mizajou Sep 16, 2026 · NCT00900198

Evaluation of Late Effects and Natural History of Disease in Patients Treated With Radiotherapy

Ap rekriteEtid obsèvasyon
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 a 120 · Tout sèks · Mizajou Sep 16, 2026 · NCT00026650

Longitudinal Studies of Patient With FPDMM

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
1 Day – 100 Years · Tout sèks · Mizajou Sep 11, 2026 · NCT03854318

Sample Collection and Tracking for the Developmental Therapeutics Clinic

Ap rekriteEtid obsèvasyon
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 a 120 · Tout sèks · Mizajou Sep 8, 2026 · NCT03269578

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Ap rekriteFaz 3
  • Sibley Memorial Hospital, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06119581

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Ap rekriteFaz 3
  • The Center for Cancer and Blood Disorders a division of American Oncology Partners, P.A., Bethesda · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06072612

Rare Tumors and Cancer Predisposition in Individuals and Families

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Tout laj · Tout sèks · Mizajou Sep 2, 2026 · NCT05350761

Psychological Benefits of a Normalized Camping Experience for Children With Cancer

Ap rekriteEtid obsèvasyon
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 7 a 25 · Tout sèks · Mizajou Aug 28, 2026 · NCT00001186

A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations

Ap rekriteFaz 1/2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 15 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT05588141

Project: Every Child for Younger Patients With Cancer

Ap rekriteEtid obsèvasyon
  • MedStar Georgetown University Hospital, Washington D.C.
  • Children's National Medical Center, Washington D.C.
  • Walter Reed National Military Medical Center, Bethesda · 7 mi lwen
Jiska laj 25 · Tout sèks · Mizajou Aug 25, 2026 · NCT02402244

Abatacept in Immune Checkpoint Inhibitor Myocarditis

Ap rekriteFaz 3
  • MedStar Health Research Institute, Georgetown University, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT05335928

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1/2
  • Johns Hopkins University, Sibley Memorial Hospital, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT05919264

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • National Institutes of Health, Bethesda · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT05592626

International Rare Brain Tumor Registry

Ap rekriteEtid obsèvasyon
  • Children's National Hospital, Washington D.C.
Jiska laj 45 · Tout sèks · Mizajou Aug 7, 2026 · NCT05697874

A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

Ap rekriteFaz 2
  • Children's National Medical Center, Washington D.C.
Laj 1 a 39 · Tout sèks · Mizajou Aug 7, 2026 · NCT05999994

Comprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDS

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
1 Day – 120 Years · Tout sèks · Mizajou Jul 23, 2026 · NCT05350748

Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • George Washington University, Washington D.C.
Laj 12 ak plis · Tout sèks · Mizajou Jul 14, 2026 · NCT05533697

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

Ap rekriteFaz 1
  • Maryland Oncology Hematology - Silver Spring /ID# 268562, Silver Spring · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT05650632

Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune)

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 3 a 100 · Tout sèks · Mizajou Jul 6, 2026 · NCT05026138

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

Ap rekriteFaz 1/2
  • Georgetown University Medical Center, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Jun 30, 2026 · NCT06162221

Molecular Genetics Studies of Cancer Patients and Their Relatives

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Suburban Hospital, Bethesda · 7 mi lwen
Tout laj · Tout sèks · Mizajou Jun 29, 2026 · NCT04185935

Childhood Cancer Survivor Study

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Children's National Medical Center, Washington D.C.
Tout laj · Tout sèks · Mizajou Jun 17, 2026 · NCT01120353

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

Ap rekrite
  • Washington DC VA Medical Center, Washington, DC, Washington D.C.
Laj 18 a 75 · Tout sèks · Mizajou Jun 17, 2026 · NCT05486572

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

Ap rekriteFaz 1/2
  • Children's National Medical Center, Washington D.C.
12 Months – 30 Years · Tout sèks · Mizajou May 19, 2026 · NCT04901702

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Ap rekriteFaz 2
  • Georgetown University Medical Center, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2026 · NCT01042379

Cancer Experience Registry (CER) for Cancer Patients and Caregivers

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Cancer Support Community Research & Training Institute, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Apr 23, 2026 · NCT02333604

Massage Impact on Sleep in Pediatric Oncology

Ap rekrite
  • Children's National Hospital, Washington D.C.
Laj 12 a 21 · Tout sèks · Mizajou Apr 15, 2026 · NCT06892158

Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)

Ap rekriteFaz 2
  • George Washington-Medical Faculty Associates, Washington D.C.
Laj 21 ak plis · Tout sèks · Mizajou Mar 3, 2026 · NCT06806930

GEMINI-NSCLC: NSCLC Biomarker Study

Ap rekriteEtid obsèvasyon
  • The Center for Cancer and Blood Disorder, Bethesda · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Feb 5, 2026 · NCT05236114

F.L.O.S.S. Project (Facilitated Lessons on Oral and Systemic Health in Survivors)

Ap rekrite
  • Georgetown Lombardi Office of Minority Health, Washington D.C.
Laj 25 a 75 · Tout sèks · Mizajou Jan 22, 2026 · NCT06315855

Testing a Web-based Intervention for Radioactive Iodine Symptom Management to Improve Health-related Quality of Life Among Differentiated Thyroid Cancer Patients

Ap rekrite
  • Georgetown University, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Jan 16, 2026 · NCT06853925

Cognitive Behavioral Theory-assisted Virtual Reality for Chronic CANcer Pain (VR-CAN)

Ap rekrite
  • MedStar Health Research Institute, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Jan 6, 2026 · NCT07318519

Digital Intervention for Symptom Management in Cancer and Opioid Sparing Using Virtual Reality (DISCOVR) Study

Ap rekrite
  • MedStar Georgetown Cancer Institute at MedStar Washington Hospital Center, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Dec 24, 2025 · NCT07228377

Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors

Ap rekriteFaz 1
  • American Oncology Partners of Maryland, Bethesda · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Dec 19, 2025 · NCT05270213

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Silver Spring · 7 mi lwen
  • Massive Bio SYNERGY-AI site, Bethesda · 7 mi lwen
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays

Ap rekriteEtid obsèvasyon
  • The Center for Cancer and Blood Disorders, Bethesda · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2025 · NCT05234177

Feasibility/Acceptability of Attentional-Control Training in Survivors

Ap rekrite
  • Children's National Hospital, Washington D.C.
Laj 8 a 16 · Tout sèks · Mizajou Jan 10, 2025 · NCT05528939

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Ap rekrite
  • MedStar Georgetown University Hospital, Washington D.C.
  • MedStar Washington Hospital Center, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Nov 27, 2024 · NCT03860883

Etid Kansè (tout kalite) nan lòt vil

Lòt etid nan Washington

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.